By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AmorChem l.p. 

1 Westmount Square
Suite 800
Montreal, Quebec    H3Z 2P9  Canada
Phone: 514-849-7696 Fax: 514-849-5191



Company News
AmorChem l.p. Release: Company Spins Out Its SEMA 3A Technology Into Semathera, With 1M$ Seed Investment 1/11/2017 12:23:58 PM
AmorChem l.p. Spins Out Its Usp15-Deubiquitinylation (Dub) Drug Discovery Platform Into Corbin Therapeutics, With A First 1M$ Seed Investment 1/9/2017 11:54:58 AM
AmorChem l.p. Spins Out Its CD36 Technology Into Mperia Therapeutics, With 1M$ Series A Investment 9/12/2016 12:47:47 PM
AmorChem l.p. Release: André-Dupont Prize Awarded To Mike Sapieha! 10/6/2015 10:33:35 AM
AmorChem l.p. Invests In Projects At The Personalized Cancer Immunotherapy Program 4/8/2015 9:24:05 AM
AmorChem l.p., Université Laval And CHU De Québec Collaborate On The Development Of A Treatment For Friedreich’s Ataxia 8/4/2014 8:51:17 AM
Roche (RHHBY) And AmorChem l.p. Announce Alliance Focused On Myotonic Muscular Dystrophy 1 7/29/2014 9:16:49 AM
AmorChem l.p. Invests In A Novel Drug For Atherosclerosis. 7/23/2014 5:16:22 PM
AmorChem l.p. Aims At Two Major Respiratory Diseases With A Single CFTR Strategy 6/18/2014 1:22:06 PM
AmorChem l.p. Invests In A Diabetic Macular Edema Opportunity 6/18/2014 12:30:28 PM